NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 12, 2018--
Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that
it will host a conference call at 4:30 p.m. ET on Monday, February 26,
2018, to discuss its financial and operating results for the fourth
quarter and full year of 2017. The Company will also provide guidance
To access the live conference call via telephone, please dial
1-866-498-8390 (U.S. callers) or 1-678-509-7599 (international callers)
and provide passcode 9165309. A live audio webcast of the call will also
be available in the Investors section of the Company’s website at www.lantheus.com.
A replay of the audio webcast will be available in the Investors section
of the Company’s website approximately two hours after completion of the
call and will be archived for 30 days.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical
Imaging, Inc. (“LMI”), a global leader in the development, manufacture
and commercialization of innovative diagnostic imaging agents and
products. LMI provides a broad portfolio of products, including the
echocardiography contrast agent DEFINITY® Vial for
(Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico and Canada. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180212006265/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
Investor Relations & Corporate Communications